E
INVO Bioscience, Inc. INVO
$2.10 -$0.10-4.55%
Recommendation
Sell
Prev Close
$1.24
Volume
76,207
Avg Vol (90D)
705,237
Market Cap
$4.84M
Dividend & Yield
--
52-Week Range
$0.50 - $3.50
P/E (TTM)
--
EPS (TTM)
-$2.38
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Weak
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
NAYA Biosciences Inc trading halted, news pending
3/17/2025 - TipRanks Financial Blog
NAYA Biosciences Inc trading halted, news pending
3/17/2025 - The Fly
NAYA Biosciences to effect 1-for-12 reverse split
3/13/2025 - The Fly
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025
3/13/2025 - Globe Newswire
NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment
2/25/2025 - GuruFocus
NAYA Biosciences supports executive order on fertility treatment access
2/25/2025 - The Fly
NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment
2/25/2025 - Globe Newswire
NAYA Biosciences Announces Nomination of New Board Members
2/19/2025 - GuruFocus
NAYA Biosciences nominates five candidates for the Board
2/19/2025 - The Fly
NAYA Biosciences Announces Nomination of New Board Members
2/19/2025 - Globe Newswire
NAYA Biosciences (NASDAQ:NAYA) Upgraded at Maxim Group
1/26/2025 - Ticker Report
NAYA Biosciences just upgraded at Maxim, here's why
1/23/2025 - The Fly
Maxim gets more bullish on NAYA Biosciences, upgrades shares
1/23/2025 - The Fly
NAYA Biosciences Raises $9.5M Amid Nasdaq Compliance Issues
1/16/2025 - TipRanks Financial Blog
NAYA Biosciences prices 13.6M units at 70c in public offering
1/13/2025 - The Fly
NAYA Biosciences prices 13.6M units at 70c in public offering
1/13/2025 - The Fly
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering
1/13/2025 - Globe Newswire
NAYA Biosciences announces development of NY-500
1/6/2025 - TipRanks Financial Blog
NAYA Biosciences announces development of NY-500
1/6/2025 - The Fly
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
1/6/2025 - Globe Newswire
NAYA Biosciences files to sell $10M of units
12/17/2024 - The Fly
NAYA Biosciences to present insights into mode of action of NY-303
10/31/2024 - The Fly
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
10/31/2024 - Globe Newswire
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma
10/24/2024 - Globe Newswire
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
10/21/2024 - Globe Newswire
Income Statement
Total Revenue (TTM)
$5.77M
EBITDA (TTM)
-$4.62M
EBIT (TTM)
-$5.24M
Net Income (TTM)
-$7.08M
Balance Sheet
Total Assets (Q)
$18.03M
Total Debt (Q)
$5.38M
Total Liabilities (Q)
$16.67M
Book Value Per Share (Q)
-$1.59
Cash Flow
Cash from Operations (TTM)
-$3.68M
Cash from Investing (TTM)
-$2.25M
Cash from Financing (TTM)
$6.76M
Net Change in Cash (TTM)
$830.50K
Filings
Filing Date
Wednesday, August 14, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Week of Nov 11 and 15 (est)
Price History
Loading...
Beta
-0.08
7-Day Total Return
200.00%
30-Day Total Return
166.16%
60-Day Total Return
171.84%
90-Day Total Return
172.73%
Year to Date Total Return
64.06%
1-Year Total Return
225.08%
2-Year Total Return
-91.53%
3-Year Total Return
-97.36%
5-Year Total Return
-98.87%
52-week Low
Oct 19, 2023 - $0.50
52-week High
Apr 17, 2024 - $3.50
Valuation
Market Cap
$4.84M - Nano Cap
Enterprise Value
$16.78M
Price/Sales (TTM)
0.78
Price/Book (Q)
-0.78
Dividends and Shares
Shares Outstanding
3.61M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.invobioscience.com
Phone Number
978 878 9505
Address
5582 Broadcast Court
Sarasota, FL 34240
Country
United States
Year Founded
2007
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device... more
NASDAQ 04/03/2025 4:00PM Eastern Quotes delayed
Weiss Ratings